Overview
Arteriosclerotic dementia with depression involves cognitive decline due to vascular pathology coexisting with depressive symptoms, posing significant challenges in geriatric care 1.Diagnosis
Presence of cognitive impairment consistent with dementia criteria (e.g., DSM-5 or ICD-10) 1.
Confirmed diagnosis of major depressive disorder using standardized psychiatric assessments 1.
Exclusion of other causes of cognitive impairment through neuroimaging and laboratory tests 1.Management
First-line treatments: Selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), atypical antidepressants, and tricyclic antidepressants 1.
Dose specifics: No specific dose recommendations provided in the reviewed studies 1.
Adjunctive therapies: Cognitive-behavioral therapy (CBT) and non-pharmacological interventions like structured activities and social support are recommended but not extensively studied in this context 1.Special Populations
Elderly: Focus on careful monitoring of cognitive effects and adverse drug reactions due to polypharmacy and comorbid conditions 1.Key Recommendations
Antidepressants show limited evidence for reducing depressive symptoms in older adults with dementia; consider individual patient response and tolerability (Evidence: Weak 1).
Cognitive state, quality of life, and functionality improvements are not consistently supported by current evidence when using antidepressants in this population (Evidence: Weak 1).
Non-pharmacological interventions should be considered alongside pharmacological treatments to address depression in arteriosclerotic dementia (Evidence: Expert opinion 1).References
1 Lenouvel E, Tobias S, Mühlbauer V, Dallmeier D, Denkinger M, Klöppel S et al.. Antidepressants for treating depression among older adults with dementia: A systematic review and meta-analysis. Psychiatry research 2024. link